TGFB1 and Schwartz-Jampel syndrome: The upregulated mRNA expression of TGF-β1 and TGF-βRII in the conjunctiva and elevated level of TGF-β1 cytokine in the tears of the SJS patients [92] suggest the involvement of TGF signaling in this disorder and thus a potential target for therapeutic intervention.